1. Phase II trial of weekly erlotinib dosing to reduce duodenal polyp burden associated with familial adenomatous polyposis. Issue 2 (30th May 2022) Authors: Samadder, N Jewel; Foster, Nathan; McMurray, Ryan P; Burke, Carol A; Stoffel, Elena; Kanth, Priyanka; Das, Rohit; Cruz-Correa, Marcia; Vilar, E; Mankaney, Gautam; Buttar, Navtej; Thirumurthi, Selvi; Turgeon, Danielle K; Sossenheimer, Michael; Westover, Michelle; Richmond, Ellen; Umar, Asad; Della... Journal: Gut Issue: Volume 72:Issue 2(2023) Page Start: 256 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗